ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,051Medicare Part D Prescriptions Filled, Including Refills

Rank: 654 out of 5176

$1.8M Total Retail Price of All Prescriptions

Rank: 71 out of 5176

619 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

6% of this provider’s 8,885 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$179 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 452 378 1 4
GLYBURIDE-METFORMIN HCL 433 340 R 2 76
CRESTOR 409 381 3 15
EVISTA 326 295 4 65
AMLODIPINE BESYLATE 325 308 5 2
ATENOLOL 324 302 6 12
METFORMIN HCL 287 250 7 7
VICTOZA 3-PAK 278 237 10 8 322
AMLODIPINE BESYLATE-BENAZEPRIL 259 240 9 55
SIMVASTATIN 248 215 10 1
TRADJENTA 237 182 10 11 436
FORTEO 213 206 12 264
DIOVAN 201 196 13 19
ACARBOSE 195 149 14 223
ATORVASTATIN CALCIUM 191 163 15 9
NEXIUM 186 173 16 16
GLIMEPIRIDE 184 146 17 37
ENALAPRIL MALEATE 173 148 18 22
PEN NEEDLE 168 147 19 144
GLYBURIDE 146 123 R 20 67
CYMBALTA 143 135 21 90
LOSARTAN POTASSIUM 135 107 22 14
TAMSULOSIN HCL 123 109 23 20
METOPROLOL SUCCINATE 112 86 24 11
UNIFINE PENTIPS 104 83 25 261
EXFORGE 98 91 26 126
ALENDRONATE SODIUM 97 81 27 18
OMEPRAZOLE 92 88 28 3
DOXAZOSIN MESYLATE 89 89 29 103
ALLOPURINOL 89 88 29 41
NOVOLOG MIX 70-30 FLEXPEN 88 78 31 290
FUROSEMIDE 87 83 32 8
LANTUS SOLOSTAR 86 64 33 70
LYRICA 83 82 34 133
LOVAZA 78 65 35 43
ONGLYZA 77 68 36 153
LIPITOR 71 69 37 51
PRANDIN 69 69 38 150
BETAMETHASONE VALERATE 68 47 39 534
JANUVIA 64 59 40 25
ISOSORBIDE MONONITRATE ER 60 50 41 44
DICLOFENAC SODIUM 56 51 42 160
LISINOPRIL 55 55 43 5
PAROXETINE HCL 55 46 43 93
CLOBETASOL PROPIONATE 52 51 45 130
BYDUREON 52 22 45 477
BENICAR 51 51 47 100
AZOR 50 46 48 194
PROCTOZONE-HC 50 50 48 171
METFORMIN HCL ER 50 37 48 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.